Tian Ma

Post-Doctoral Fellow, Dartmouth College, Hanover, New Hampshire


  • PhD '13, Pharmacology, Toxicology and Molecular Therapeutics, Dartmouth College
  • BS '07, University of Toronto

Selected Publications

  • Ma T, Lopez-Aguiar AG, Li A, Lu Y, Sekula D, Nattie EE, Freemantle S, Dmitrovsky E. Mice lacking G0S2 are lean and cold-tolerant. Cancer Biol Ther. 2014; 15(5):643-50.

  • Ma T, Galimberti F, Erkmen CP, Memoli V, Chinyengetere F, Sempere L, Beumer JH, Anyang BN, Nugent W, Johnstone D, Tsongalis GJ, Kurie JM, Li H, Direnzo J, Guo Y, Freemantle SJ, Dragnev KH, Dmitrovsky E. Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer. Mol Cancer Ther. 2013; 12(8):1545-55.

  • Ma T, Dong JP, Sekula DJ, Fei DL, Lamph WW, Henderson M, Lu Y, Blumen S, Freemantle SJ, Dmitrovsky E. Repression of exogenous gene expression by the retinoic acid target gene G0S2. Int J Oncol. 2013; 42(5):1743-53.

  • Ma T, Fuld AD, Rigas JR, Hagey AE, Gordon GB, Dmitrovsky E, Dragnev KH. A phase I trial and in vitro studies combining ABT-751 with Carboplatin in previously treated non-small cell lung cancer patients. Chemotherapy 2012; 58:321-9.

+ View more